Medical products are designed to fix a problem, but sadly they often have side effects worse than the original issue.
A New Jersey State court jury agreed on a $15 million verdict against a pelvic mesh implant unit. The lawsuit, filed against pelvic mesh implants, was only the second to go to trial out of 9,000 pending cases. The first trail was in 2013, with an $11.1 million verdict. The company plans to appeal the verdict.
A painful chemical reaction
The devices were surgically implanted in women to treat urinary incontinence and pelvic organ prolepses. The mesh devices contain a chemical that can react with human tissue. If the reaction occurs, the implanted units become stiff and brittle. As a result, the women experienced chronic pain and debilitating side effects. The pelvic mesh units were designed to help avoid more invasive surgeries.
A reclassification as evidence mounts
The product was pulled from the market in 2012. In 2016 the United States Food & Drug Administration (FDA) reclassified pelvic mesh implantations as a high-risk procedure. Prior to then it was considered a moderate risk procedure. The reclassification requires manufacturers to address safety concerns and submit a premarket approval (PMA) application to the FDA. It is important to note, the FDA only reclassified pelvic mesh procedures and not mesh used for incontinence.
If you are suffering from a defective medical product make sure to seek medical care. Once you are able, document your claim in any way possible. Keep medical bills and records, and make notes of your symptoms, including dates and times. Contacting an attorney that specializes in product liability can help you get compensation. Any information you have to support your case will help your attorney.